Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1 4Phase 3 2Phase 1/2 2Phase NA 1Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Urinary Bladder Neoplasms 1Ureteral Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Melanoma 1Lung Neoplasms 1Endometrial Neoplasms 1Castration Resistant Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Carcinoma, Ductal 1

Interventions

Medroxyprogesterone Acetate 3semaglutide 1pazopanib 1palbociclib 1olaparib 1lenvatinib 1fluciclovine F-18 1ferrous gluconate 1dostarlimab 1Watchful Waiting 1Sunitinib 1Specimen Handling 1Resistance Training 1Progestins 1Observation 1Nutrition Assessment 1Metformin 1Megestrol Acetate 1Magnetic Resonance Spectroscopy 1LY 353381 1Indocyanine Green 1Hysteroscopy 1High-Energy Shock Waves 1Estrogen Replacement Therapy 1Biomarkers 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Endometrial Neoplasms × Specimen Handling × Clear all
NCT07281547 2026-02-18

Low Dose Aspirin to Lower Inflammation and Prevent Endometrial Cancer in Postmenopausal Women With Non-atrophic Endometrial Changes and Pain

Mayo Clinic

Phase 4 Not yet recruiting
25 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡